v3.10.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Cash flows from operating activities:      
Net income $ 38,062 $ 25,170 $ 18,799
Reconciliations of net income to net cash from operating activities:      
Depreciation and amortization 4,219 5,452 3,253
Losses (gains) recognized on investments 163 (51) (3)
Losses recognized on sale of property 64   31
Deferred income taxes (1,192) 4,039 (1,704)
Share-based compensation 5,502 4,184 2,782
Excess tax from share-based compensation     (253)
Changes in certain operating assets and liabilities:      
Trade accounts receivable (14,933) (10,180) (35,955)
Income taxes receivable 1,686 (1,686) 1,038
Prepaid expenses and other (8,156) (1,825) (726)
Accounts payable (830) 222 1,727
Accrued payroll, payroll taxes and related benefits (21,863) 28,529 31,767
Other accrued liabilities 12,550 1,350 1,508
Income taxes payable 4,403 (3,041) 3,294
Workers' compensation claims liabilities 49,632 57,140 51,235
Safety incentives liability 678 3,697 3,582
Customer deposits, long-term liabilities and other assets, net (201) (141) (68)
Net cash provided by operating activities 69,784 112,859 80,307
Cash flows from investing activities:      
Purchase of property and equipment (5,679) (3,687) (7,106)
Proceeds from sale of property 485   1,459
Purchase of investments (1,946) (6,283) (264)
Proceeds from sales and maturities of investments 1,885 10,718 4,796
Purchase of restricted investments (108,739) (381,207) (28,072)
Proceeds from sales and maturities of restricted investments 74,650 55,482 34,878
Net cash (used in) provided by investing activities (39,344) (324,977) 5,691
Cash flows from financing activities:      
Proceeds from credit-line borrowings 8,500 24,899 14,868
Payments on credit-line borrowings (8,500) (24,899) (14,868)
Payments on long-term debt (220) (221) (15,220)
Common stock repurchased on vesting of restricted stock units (2,952) (1,673) (433)
Dividends paid (7,348) (7,276) (6,359)
Proceeds from exercise of stock options 577 163 72
Excess tax benefits from share-based compensation     253
Net cash used in financing activities (9,943) (9,007) (21,687)
Net increase (decrease) in cash, cash equivalents and restricted cash 20,497 (221,125) 64,311
Cash, cash equivalents and restricted cash, beginning of period 120,205 341,330 277,019
Cash, cash equivalents and restricted cash, end of period $ 140,702 $ 120,205 $ 341,330

Source